VP, Global Clinical Dev, CNS & Digital Medicine
Timothy Peters-Strickland, M.D., joined OPDC in April 2012, and has a current title of Vice President, Global Clinical Development, CNS and Digital Medicine. He has served as Medical/Project Lead on various CNS projects, including Abilify Maintena (various indications) and Digital Medicine-Aripiprazole. Over the past 3 years, Timothy led the filing teams for Abilify Maintena which has led to multiple approvals in the US, Canada, and EU. Of note, he led Otsuka’s Digital Medicine Program and received FDA approval in November 2017 for Abilify MyCite, the world’s first digital medicine.
Timothy joined OTSUKA from Covance, Inc. where he was Medical Director, Global Clinical Practice for 3.5 years prior. He has also published a book, Basic Psychopharmacology for Mental Health Professionals (3rd Edition), along with Richard Sinacola, Ph.D., and Joshua Wyner, Ph.D. Earlier in his career, Timothy has worked in private psychiatric practice, in community mental health settings, and has been volunteer faculty at University of Southern California (USC) Department of Psychiatry.
Timothy completed this Psychiatry Residency training at USC where he served as Chief Resident. He earned his Doctor of Medicine from the University of Florida in Gainesville and his Bachelor of Science in Biochemistry from Florida State University in Tallahassee.